SEC Filing Summary: Stellar Biotechnologies Inc. (Form 6-K)
Business Context and Reporting Period
This Form 6-K was filed by Stellar Biotechnologies Inc. on August 30, 2013, covering the month of August 2013. The registrant is a foreign issuer filing under Form 20-F. The filing serves primarily to disclose the execution of a new License Agreement with the University of Guelph, submitted as Exhibit 99.1.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a disclosure of a corporate event rather than a financial statement.
Material Changes
The material change disclosed is the entry into a License Agreement with the University of Guelph. No financial performance changes or comparative period data are included in this document.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. The document is limited to the formal signature and the attachment of the license agreement.
Investor Verification Checklist
- Verify the specific terms and scope of the License Agreement with the University of Guelph (Exhibit 99.1).
- Confirm the registrant's current name, as the metadata references "Edesa Biotech, Inc." while the filing explicitly names "Stellar Biotechnologies Inc."
- Review subsequent filings for financial impact resulting from this new license agreement.